Skip to content
VeranaHealth_Logo
  • Clinicians
    • Verana Trial Connect
    • Verana Quality Measures
    • Verana Research Network
    • VeraSite for Clinicians
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Partners
    • Societies
    • CROs
    • Technology and Data
  • Company
    • About
    • Team
    • Press
    • Blog
    • Careers
    • Privacy
      • Patient Privacy
      • Privacy Policy
  • Solutions
    • Ophthalmology Qdata
      • Anti-VEGF
      • Geographic Atrophy
      • Glaucoma
      • Other Ophthalmic Conditions
      • VeraSite
    • Neurology Qdata
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
      • Other Neurological Conditions
    • Urology Qdata
      • Bladder Cancer
      • Prostate Cancer
      • Other Urological Conditions
Contact Us
Ophthalmology

24 Month Real-World Study of Intraocular Pressure and Medication Reduction in Ab Interno Microinvasive Glaucoma Surgery Combined with Cataract Surgery Compared with Cataract Surgery Only: An IRISⓇ Registry Study

September 20, 2023
→
Ophthalmology

NVS019: Real-world evaluation of amblyopic patient characteristics, clinical outcomes, and treatment patterns using the IRIS Registry

March 2023
→
Ophthalmology

Emulating VIEW 1 and VIEW 2 Clinical Trial Outcome Data Using the American Academy of Ophthalmology IRIS Registry

January 2023
→
Urology

Insights from the AQUA Registry: A Retrospective Study of Anticholinergic Polypharmacy in the United States

January 2023
→
Urology

Patterns of Surgical Management of Male Stress Urinary Incontinence: Data from the AUA Quality (AQUA) Registry

January 2023
→
Ophthalmology

Simultaneous Adjustment of Uncontrolled Confounding, Selection Bias, and Misclassification in Multiple-Bias Modelling

January 2023
→
Ophthalmology

Dry Age-Related Macular Degeneration: Distribution of Visual Acuity and Progression Risk in a Large Registry

November 2022
→
Ophthalmology

NVS037: Real-world brolucizumab effectiveness and durability in neovascular age-related macular degeneration in the U.S.: Findings from the IRIS Registry

November 2022
→
Ophthalmology

SG001: Glaucoma Medication Use in Patients with a Mild Glaucoma Severity After Receiving MIGS: An Academy IRIS® Registry Analysis

October 2022
→
Ophthalmology

Effectiveness and Durability of Brolucizumab Treatment in Real-World Neovascular Age-Related Macular Degeneration (nAMD) Patients in the U.S.: Findings from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)

October 2022
→
Ophthalmology

Real-World Safety Analysis of an Intracanalicular Dexamethasone Insert Using the Academy’s IRIS® Registry

October 2022
→
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 13
  • Next »
Search
VeranaHealth_Logo

San Francisco | New York | Knoxville

  • Company
    • About
    • Team
    • Press
    • Blog
  • Research
  • Solutions
    • VeraQ
    • Qdata
    • Ophthalmology Qdata
    • Neurology Qdata
    • Urology Qdata
  • Clinicians
  • Life Sciences
  • Careers
Search

© 2023 Verana Health. All Rights Reserved.

Privacy Policy

veranahealth.com
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}